Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
post cyber monday sale post cyber monday sale

MODERNA Stock Plunges as Public Loses Interest in More Covid Jabs

  • November 02, 2023

Moderna may be riding a wave with third quarter earnings report higher than expected, but all the same, it’s still posting losses to the tune of a 15% plunge. The company is blaming a stockpile of unused COVID vaccines and consumer lack of interest in the shots for the downturn and is projecting lower returns for 2024. So far, the losses per share are $9.53, with $43 billion less in return than expected. According to CNBC, Moderna’s stock is down more than 57% overall for the year...